Soligenix, Inc. (SNGX)
0.3681
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
0.3681
0.00 (0.00%)
After-Hours: 20:00
Soligenix Total Liabilities (Quarterly) : 3.854M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.854M |
| March 31, 2026 | 3.833M |
| December 31, 2025 | 3.943M |
| September 30, 2025 | 3.696M |
| June 30, 2025 | 3.932M |
| March 31, 2025 | 4.134M |
| December 31, 2024 | 4.848M |
| September 30, 2024 | 4.542M |
| June 30, 2024 | 6.400M |
| March 31, 2024 | 7.29M |
| December 31, 2023 | 7.275M |
| September 30, 2023 | 7.082M |
| June 30, 2023 | 8.026M |
| March 31, 2023 | 14.49M |
| December 31, 2022 | 16.75M |
| September 30, 2022 | 16.92M |
| June 30, 2022 | 17.11M |
| March 31, 2022 | 17.09M |
| December 31, 2021 | 16.15M |
| September 30, 2021 | 14.66M |
| June 30, 2021 | 14.01M |
| March 31, 2021 | 14.23M |
| December 31, 2020 | 16.15M |
| September 30, 2020 | 5.845M |
| June 30, 2020 | 6.230M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.333M |
| December 31, 2019 | 6.318M |
| September 30, 2019 | 5.654M |
| June 30, 2019 | 5.557M |
| March 31, 2019 | 4.240M |
| December 31, 2018 | 4.212M |
| September 30, 2018 | 4.021M |
| June 30, 2018 | 3.529M |
| March 31, 2018 | 3.408M |
| December 31, 2017 | 3.230M |
| September 30, 2017 | 2.708M |
| June 30, 2017 | 3.152M |
| March 31, 2017 | 2.593M |
| December 31, 2016 | 2.870M |
| September 30, 2016 | 5.583M |
| June 30, 2016 | 5.382M |
| March 31, 2016 | 6.641M |
| December 31, 2015 | 7.405M |
| September 30, 2015 | 6.822M |
| June 30, 2015 | 8.886M |
| March 31, 2015 | 7.728M |
| December 31, 2014 | 7.108M |
| September 30, 2014 | 10.55M |
| June 30, 2014 | 10.81M |
| March 31, 2014 | 11.12M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.50M |
| Shareholders Equity (Quarterly) | 6.646M |
| Debt to Equity Ratio | 0.0455 |
| Current Ratio | 2.769 |
| Net Debt Paydown Yield | -0.52% |